COVID-19 VACCINATIONS: If, in addition to indemnity for your main employment, you would like cover for delivering COVID-19 Vaccinations please apply for our standalone extension Apply Today

Home  »   Latest News   »   PDA highlights several emerging but highly significant matters to the Health and Social Care Committee

PDA highlights several emerging but highly significant matters to the Health and Social Care Committee

Following on from the oral evidence provided to the Health and Social Care select committee’s pharmacy inquiry in January 2024, the PDA has submitted written supplementary evidence which highlights a number of emerging but highly significant matters.

Thu 14th March 2024 The PDA

The PDA’s supplementary evidence explores issues of importance to pharmacists such as the workforce, the introduction of the Pharmacy First Service, the recent pharmacy supervision consultation, and more.

With regards to issues surrounding the workforce, the PDA has given evidence of matters that pharmacists have reported about their lived experiences in the workplace that impact their health and well-being. These issues include chronic understaffing, sub-standard working environments, an absence of a protected training time, and experiences of racism, violence and abuse.

The PDA’s supplementary evidence then goes on to discuss the introduction of the Pharmacy First Service. The evidence states that although in general, PDA members working in England welcome the development of services such as the Pharmacy First Service, they have also raised significant concerns about the timescales and methods of implementation of the service.

The evidence also expresses how the PDA believes that the proposals around supervision legislation recently under consultation by the Department of Health and Social Care need to be very carefully considered to ensure that the workforce and skill mix are appropriately enabled.

The supplementary evidence also highlights a small number of emerging but highly significant matters of relevance to the inquiry. These matters have been covered in the written evidence as there was not sufficient time to cover the issues when giving oral evidence.

Read the PDA’s supplementary evidence below:

thumbnail of Supplementary written evidence submitted by The Pharmacists’ Defence Association

The PDA will continue its ongoing work to protect, defend, lobby for, and support the interests and reputations of pharmacists.

Learn more

Not yet a PDA Member?

If you have not yet joined the PDA, we encourage you to join today and ask your colleagues to do the same.

Membership is FREE to pharmacy students, trainee pharmacists and for the first three months of being newly qualified.


Read about our key member benefits here.







The Pharmacists' Defence Association is a company limited by guarantee. Registered in England; Company No 4746656.

The Pharmacists' Defence Association is an appointed representative in respect of insurance mediation activities only of
The Pharmacy Insurance Agency Limited which is registered in England and Wales under company number 2591975
and is authorised and regulated by the Financial Conduct Authority (Register No 307063)

The PDA Union is recognised by the Certification Officer as an independent trade union.

Cookie Use

This website uses cookies to help us provide the best user experience. If you continue browsing you are giving your consent to our use of cookies.

General Guidance Resources Surveys PDA Campaigns Regulations Locums Indemnity Arrangements Pre-Regs & Students FAQs Coronavirus (COVID-19)